Anavex Life Sciences (AVXL) Common Equity (2010 - 2026)
Anavex Life Sciences (AVXL) posted Common Equity of $112.45 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 23.6% from $90.96 million a year earlier but down 7.6% from the prior quarter.
Powered by 
Analysis
Anavex Life Sciences (AVXL) Common Equity (2010 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Anavex Life Sciences' Common Equity came in at $94.87 million, down 21.1% from FY2024.
- Annual Common Equity has declined for four consecutive fiscal years, though with a five-year compound annual growth rate of 28.3% (FY2020 to FY2025).
- In prior fiscal years, Anavex Life Sciences' Common Equity was $120.26 million in FY2024 (-15.2%), $141.85 million in FY2023 (-0.4%), $142.49 million in FY2022 (-5.5%) and $150.82 million in FY2021 (+453.7%).
- Quarterly Common Equity has run from a low of $90.96 million in fiscal Q3 2025 to a high of $152.21 million in fiscal Q2 2022 over five years.
- On a year-over-year basis, Common Equity has increased in each of the last three quarters, with an average decline of 6.3% over the last eight quarters.
- The strongest year-over-year quarter for Common Equity in the past five years was fiscal Q4 2021, with growth of 453.7%; the weakest was fiscal Q3 2025, with a decline of 29.9%.
- According to Business Quant data, Common Equity for the three prior fiscal quarters was $121.71 million (Q2 2026), $126.62 million (Q1 2026) and $94.87 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Anavex Life Sciences | 187.25 Mn | -292.83 Mn | - | 112.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 112.45 Mn |
| Mar 31, 2026 | 121.71 Mn |
| Dec 31, 2025 | 126.62 Mn |
| Sep 30, 2025 | 94.87 Mn |
| Jun 30, 2025 | 90.96 Mn |
| Mar 31, 2025 | 99.76 Mn |
| Dec 31, 2024 | 110.92 Mn |
| Sep 30, 2024 | 120.26 Mn |
| Jun 30, 2024 | 129.78 Mn |
| Mar 31, 2024 | 134.96 Mn |
| Dec 31, 2023 | 135.58 Mn |
| Sep 30, 2023 | 141.85 Mn |
| Jun 30, 2023 | 146.76 Mn |
| Mar 31, 2023 | 145.17 Mn |
| Dec 31, 2022 | 135.12 Mn |
| Sep 30, 2022 | 142.49 Mn |
| Jun 30, 2022 | 150.74 Mn |
| Mar 31, 2022 | 152.21 Mn |
| Dec 31, 2021 | 146.37 Mn |
| Sep 30, 2021 | 150.82 Mn |
API Access
Anavex Life Sciences Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=AVXL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "AVXL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=AVXL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();